All Eaisi articles
-
News
MHRA approves Leqembi IV maintenance as additional Alzheimerās option
Decision provides UK Alzheimerās patients with an alternative administration method for Eisai and Biogenās antibody drug.
-
NewsAlzheimerās drug milestone ābittersweetā for certain patients
The first new dementia medicine to be licensed in over two decades shows for first time, that the course of Alzheimer disease can be modified and slow cognitive decline.